EP0716709A1 - Enhanced expression in plants using non-translated leader sequences - Google Patents
Enhanced expression in plants using non-translated leader sequencesInfo
- Publication number
- EP0716709A1 EP0716709A1 EP94929179A EP94929179A EP0716709A1 EP 0716709 A1 EP0716709 A1 EP 0716709A1 EP 94929179 A EP94929179 A EP 94929179A EP 94929179 A EP94929179 A EP 94929179A EP 0716709 A1 EP0716709 A1 EP 0716709A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sequence
- gene
- plant
- translated
- translated leader
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Definitions
- the present invention is related to the genetic engineering of plants.
- the present invention relates to recombinant expression systems using non-translated leader sequences derived from heat shock proteins for the enhanced expression of proteins in plants.
- Recombinant genes for producing proteins in plants comprise in sequence the following operably linked elements: a promoter which functions in plants, a structural gene encoding the target protein, and a non-translated region which also functions in plants to cause the addition of polyadenylated nucleotides to the RNA sequence.
- a promoter which functions in plants
- a structural gene encoding the target protein and a non-translated region which also functions in plants to cause the addition of polyadenylated nucleotides to the RNA sequence.
- One advantage of higher levels of expression is that fewer numbers of transgenic plants would need to be produced and screened in order to recover plants which produce agronomically significant quantities of the target protein.
- High level expression of the target protein often leads to plants which exhibit commercially important properties.
- Improved recombinant plant genes have been generated by using stronger promoters, such as promoters from plant viruses. Further improvements in expression have been obtained in gene constructs by placing enhancer sequences 5' to the promoter. Still further improvements have been achieved, especially in monocot plants, by gene constructs which have introns in the non-translated leader positioned between the promoter and the structural gene coding sequence. For example, Callis et al. (1987) Genes and Development. Vol. 1, pp.
- leader sequences are by definition located at the 5' end of the mRNA and are untranslated.
- the leader sequence is further defined as that portion of the mRNA molecule which extends from the 5' CAP site to the AUG protein translation initiation codon. This region of the mRNA plays a critical role in translation initiation and in the regulation of gene expression. For most eukaryotic mRNAs, translation initiates with the binding of the CAP binding protein to the mRNA cap. This is then followed by the binding of several other translation factors, as well as the 43S ribosome pre-initiation complex.
- This complex travels down the mRNA molecule while scanning for a AUG initiation codon in an appropriate sequence context. Once this has been found and with the addition of the 60S ribosomal subunit, the complete 80S initiation complex initiates protein translation (Pain 1986; Moldave 1985; Kozak 1986). A second class of mRNAs have been identified which possess translation initiation features different from those described above.
- leader sequences Like the TMV leader sequence, most 5' untranslated leader sequences are very A,U rich and are predicted to lack any significant secondary structure.
- One of the early steps in translation initiation is the relaxing or unwinding of the secondary mRNA structure (Sonenberg 1990).
- Messenger RNA leader sequences with negligible secondary structure may not require this additional unwinding step and may therefore be more accessible to the translation initiation components.
- Introducing sequences which can form stable secondary structures reduces the level of gene expression (Kozak 1988; Pelletier and Sonenberg 1985). The ability of a leader sequence to interact with translational components may play a key role in affecting levels of subsequent gene expression.
- heat shock genes were scrutinized. Regulation of heat shock genes has been shown to occur at the transcriptional and translational level (Baumann et al. 1987; Kimpel and Key, 1985). Heat shock genes may be induced and expressed in response to hyperthermic stress (Key et al. 1981), as well as in response to other environmental conditions. During heat shock there is preferential translation of heat shock mRNAs (Storti et al. 1980). The translational control has been shown to be determined by the 5' untranslated leader sequence (McGarry and Lindquist 1985).
- a heat shock mRNA leader sequence operably linked to the mRNA of a non-heat shock gene would facilitate translation during heat shock conditions (Klemenz et al. 1985). The specific aspects of this regulation are not known.
- the heat shock mRNA 5' leader sequence may be more efficient at initiating translation, or may contain a particular structural feature that allows preferential translation during heat shock. Whatever the mechanism, the characteristics of the heat shock mRNA leader sequence may also provide an improvement to gene expression during non-heat shock conditions.
- This invention makes a significant contribution to the art by providing non-translated leader sequences for use in genetic constructs which enhance gene expression in plants.
- the 5' non-translated leader sequences described herein provide for a significant increase in expression over other non-translated leader sequences which have been previously employed by those skilled in the art.
- DNA molecule which comprises:
- RNA sequence which is operably linked to RNA sequence (a) a promoter which functions in plant cells to cause the production of an RNA sequence; which is operably linked to (b) a non-translated leader sequence derived from a heat shock protein, wherein said non-translated leader sequence is heterologous to said promoter; which is operably linked to
- transforming plant cells with a DNA molecule which comprises: (i) a promoter region which functions in plant cells to cause the production of an RNA sequence; which is operably linked to
- a structural DNA sequence,wnereinsaid structural DNA sequence is heterologous to said non-translated leader sequence; which is operably linked to
- Yet another object of the present invention is to provide a transformed plant which contains a DNA molecule which comprises: (a) a promoter which functions in plant cells to cause the production of an RNA sequence; which is operably linked to (b) a non-translated leader sequence derived from a heat shock protein, wherein said non-translated leader sequence is heterologous to said promoter; which is operably linked to
- FIG. 1 illustrates the petunia HSP70 leader sequence (SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO.3, and SEQ ID NO.4).
- FIG. 2 illustrates the soybean HSP17.9 leader sequence (SEQ ID NO.5 and SEQ ID NO.6).
- FIG. 3 illustrates the maize HSP70 leader sequence (SEQ ID NO.7, SEQ ID NO.8, SEQ ID NO.9, and SEQ ID NO.10).
- Figure 4 illustrates the AMV leader sequence (SEQ ID NO.11 and SEQ ID NO.12).
- Figure 5 illustrates the TMV leader sequence (SEQ ID N0.13 and
- Figure 6 illustrates the AMV-B leader sequence (SEQ ID NO.15 and SEQ ID NO.16).
- FIG. 7 illustrates the TMV-B leader sequence (SEQ ID NO. 17 and SEQ ID N0.18).
- Figure 8 illustrates the Soybean HSP17.9 -B leader seuence (SEQ ID NO.19 and SEQ ID NO. 20).
- Figure 9 illustrates the Petunia HSP70 -B leader sequence (SEQ ID NO.21 and SEQ ID NO.22).
- Figure 10 illustrates pMON755.
- Figure 11 illustrates pMON8796.
- Figure 12 illustrates pMON772.
- Figure 13 illustrates pMON10871.
- Figure 14 illustrates pMON10086.
- Figure 15 illustrates pMON10028.
- Enhanced gene expression in plants is herein provided by the use of 5' non- translated leader sequences derived from heat shock proteins in genetic constructs. Plant gene expression employing vectors containing same may be evaluated in order to determine whether or not said expression is in fact enhanced by the use of a heat shock 5' non- translated leader sequence during non-heat shock conditions.
- Heat shock proteins are proteins which are induced in response to a particular stress-related event.
- the heat shock response is not limited to plants, and has been noted in organisms as diverse as Drosophila, Escherichia coli, Saccharomyces cerevisiae, and humans.
- the particular stress-related event is also not solely limited to an increase in temperature as the name "heat shock protein” would suggest.
- Other stress-related events which induce heat shock proteins include, for example, an exposure to ethanol, arsenite, heavy metals, a ino acid analogues, glucose starvation, calcium ionophores, and a number of other treatments.
- Heat shock proteins are typically designated as HSPX, wherein X is a number which reflects the molecular weight of the protein in question.
- Suitable heat shock proteins from which 5' non-translated leader sequences could be isolated include but are not limited to HSP70 from petunia, HSP17.3, 17.5, 17.9, 18.5, and 26 from soybean, and HSP18, 22, 27, 65, 68, 70, 72, 77, 78, 79, 85, and 87 from maize.
- Said 5' non- translated leader sequences are selected such that the leader sequences provide for enhanced expression in plants.
- those of skill in the art would recognize that certain optimizations of the 5' non-translated leader sequences disclosed herein may in fact be made such that the expression levels may be altered.
- these optimizations may involve changes in the nucleotide sequence of the leader such that a change in the secondary structure results therefrom. It is speculated that the secondary structure of the leader is required for the enhancement of expression; the specific nucleotide sequence of the leader is important insofar as the secondary structure is concerned. Therefore, the leader sequence may in fact tolerate modifications in the nucleotide sequence which do not result in changes in the secondary structure. These changes would not affect the resulting expression levels, and are in fact contemplated by the present invention.
- Preferred for the practice of the present invention are those 5' non-translated leader sequences selected from the group consisting of petunia HSP 70 , soybean HSP17.9 and the Maize HSP70.
- the 5' non-translated leader sequences from plant heat shock genes have been shown to regulate gene expression during heat shock conditions.
- the mechanism for this selective or enhanced expression may in fact extend to non-heat shock conditions, thereby providing a means for selectively increasing plant gene expression.
- Several plant heat shock 5' non-translated leader sequences have been evaluated for their effect on plant gene expression during non-heat shock conditions.
- 5' non-translated leader sequences were tested in dicot and monocot species using both transient and stable plant transformation assays.
- the 5' non-translated leader sequence may be isolated from a gene expressing a known heat shock protein by methods known to those of skill in the art, or alternatively, may be synthesized from a known sequence.
- all leaders were generated as synthetic oligonucleotides and were tested with several different genes to show that the enhanced expression was general and not gene specific. Data demonstrating this is included in the Example.
- Nucleic acid sequences which contain a 5' non-translated sequence may also be obtained by using the specific 5' non-translated sequences disclosed herein as probes. These obtained sequences could then be evaluated for enhanced expression in plants.
- the nucleotide sequence of the 5' non-translated leader sequence may be modified at the 5' and 3' ends to facilitate cloning. This may be accomplished by site-directed mutagenesis, using the method described by Kunkel (1985), and may provide different restriction sites as needed. Various oligonucleotide primers may be used to modify the 5' and 3' ends. Multilinkers may be utilized, which facilitate ordered assembly of the heterologous DNA sequence. Sequencing of the respective 5' non-translated leader sequence may be performed by the method of Sanger and Coulson, Proc. Nat'l Acad. Sci. 74: 5463-5467 (1977) using a Sequenase ® product, according to the manufacturer's instructions.
- Expression levels of the various constructs may be evaluated by comparing the level of expression with that obtained using a known leader sequence, such as, for example, those 5' non-translated leader sequences obtained from TMV- Omega and AMV as discussed previously, wherein the baseline of expression is that obtained using the known leader sequence.
- a known leader sequence such as, for example, those 5' non-translated leader sequences obtained from TMV- Omega and AMV as discussed previously, wherein the baseline of expression is that obtained using the known leader sequence.
- the instant invention embraces the additional feature that the enhanced expression of genes using the 5' non-translated leader sequences occurs during non- heat shock conditions.
- the use of 5' non-translated leader sequences may result in overall expression levels which vary from gene to gene. This variability may in fact be due to a number of reasons including but not limited to the efficiency of expression of a particular gene.
- the expression of a Bacillus thuringiensis toxin gene using the 5' non- translated leader sequences may be lower than the expression of an ACC deaminase gene using the same general construct as is taught by the instant invention.
- One postulated explanation for the cause of lower expression is the possible presence of fortuitous transcription processing sites, which could produce aberrant forms of the Bacillus thuringiensis mRNA transcript as is discussed in Koziel et al., WO 93/07278.
- These aberrantly processed transcripts may be non ⁇ functional in a plant, in terms of producing an insecticidal protein.
- Possible processing sites include polyadenylation sites, intron splicing sites, transcriptional termination signals, and transport signals. The fortuitous occurrence of such processing sites in a coding region might complicate the expression of that gene in transgenic hosts, which may include improper processing in plants.
- a series of plasmids or vectors may be constructed, wherein the vectors would each contain a different heat shock 5' non-translated leader sequence fused to a particular reporter or structural gene. The level of reporter gene activity would then be measured and compared with the activity of vectors which contained previously described plant virus leader sequences such as the TMV and AMV leader sequences previously described.
- Two dicot heat shock 5' leader sequences, the petunia HSP70 (Winter et al. 1988) and soybean HSP17.9 (Raschke et al. 1988 ) leader sequences were shown to increase levels of gene expression in a dicot system.
- the maize HSP70 5' leader sequence was shown to increase levels of gene expression in maize cells (a monocot system) (pMON9508 - Rochester et al. 1986).
- the 5' non-translated leader sequence for the soybean (Raschke et al. 1988) and maize (Roley et al. 1986) heat shock mRNAs was derived using published information detailing the start of transcription and translation for each heat shock gene.
- the start of translation is known for the petunia HSP70 mRNA. However, the start of transcription has not been determined.
- a start site was therefore chosen (base 144 - Winter et al. 1988) based on the putative TATA box (bases 108 - 115, Winter et al. 1988; Joshi 1987) and from preliminary, unpublished experiments performed in order to determine the transcriptional start site.
- the TMV and AMV viral leaders were also constructed using synthetic oligonucleotides which contained the consensus 5' and 3' sequences as represented in the Example below.
- nucleotide and/ or amino acid sequences disclosed herein are representative in the sense that equivalent genes or portions thereof may be obtained and/ or generated pursuant to this disclosure. By equivalent it is meant that said gene or portion thereof would function in a manner substantially the same as the gene disclosed herein, and would provide a benefit or particular characteristic to a plant in substantially the same manner.
- a structural DNA sequence encoding a particular gene of interest may be inserted into a plant transformation vector.
- a gene is defined as an element or combination of elements that are capable of being expressed in a cell, either alone or in combination with other elements.
- a gene comprises (from the 5' to the 3' end): (1) a promoter region which may include a 5' non-translated leader sequence capable of functioning in plant cells; (2) a structural gene or structural DNA sequence which codes for the desired protein; and (3) a 3' non-translated region, which typically causes the termination of transcription and the polyadenylation of the 3' region of the RNA sequence.
- Each of these elements is operably linked to the adjacent element.
- a gene comprising the above elements may be inserted by standard recombinant DNA methods into a plant transformation vector. Some or all of the elements of the gene may be present, with additional or remaining elements added to the vector if necessary. Additionally, the plant transformation vector may be constructed with all of the elements present except for the structural gene, which may then be added at an appropriate time by known methods.
- the segment of DNA referred to as the promoter is responsible for the regulation of the transcription of DNA into mRNA.
- a number of promoters which function in plant cells are known in the art and may be employed in the practice of the present invention. These promoters may be obtained from a variety of sources such as plants or plant viruses, and may include but are not limited to promoters isolated from the caulimovirus group such as the cauliflower mosaic virus 35S promoter (CaMV35S), the enhanced cauliflower mosaic virus 35S promoter (CaMVe35S) , the figwort mosaic virus full-length transcript promoter (FMV), and the promoter isolated from the chlorophyll a/b binding protein as is known in the art.
- CaMV35S cauliflower mosaic virus 35S promoter
- CaMVe35S enhanced cauliflower mosaic virus 35S promoter
- FMV figwort mosaic virus full-length transcript promoter
- promoters which are capable of expressing the replicase enzyme in an inducible manner or in a tissue-specific manner in certain cell types in which the infection is known to occur.
- the inducible promoters from phenylalanine ammonia lyase, chalcone synthase, hydroxyproline rich glycoprotein, extensin, pathogenesis-related proteins (e.g. PR- la) , and wound-inducible protease inhibitor from potato would be useful.
- promoters such as the promoter from glutamine synthetase for expression in vascular tissues or promoters from epidermal cells, could be used to express the protein in certain cell types.
- the patatin promoter could be used to express the protein in the tuber.
- the particular promoter selected is preferably capable of causing sufficient expression of the structural gene to which it is operably linked to result in the production of a suitable amount of the respective protein, but not so much as to be detrimental to the cell in which it is expressed.
- the promoters selected should be capable of functioning in tissues including but not limited to epidermal, vascular, and mesophyll tissues. The actual choice of the promoter is not critical, as long as it has sufficient transcriptional activity to accomplish the expression of the structural gene.
- the non-translated leader sequence can be derived from any suitable source and may be specifically modified to increase the translation of the mRNA.
- the 5' non-translated region may be obtained from the promoter selected to express the gene, the native leader sequence of the gene or coding region to be expressed, viral RNAs, suitable eucaryotic genes, or a synthetic gene sequence.
- the 5' non-translated leader sequence may be heterologous to the promoter employed in the construct, for example, the non-translated leader sequence may be derived from an unrelated promoter as described.
- the present invention is not limited to the constructs presented in the following Example.
- the structural DNA sequence which codes for the structural gene may be isolated from a particular source using methods known to those of skill in the art as discussed earlier in this section. Other modifications to this gene may also be made, including modifications to the 5' or 3' termini of the structural gene, such as, for example, the introduction of an initiation codon at the 5' end. Such structural genes may in fact be heterologous to the 5' non-translated leader sequence.
- Suitable structural genes which may be employed in the practice of the present invention include those structural genes selected from the group consisting of ACC deaminase, PLRV replicase, viral coat proteins, EPSP synthase or other genes conferring herbicide tolerance, selectable marker genes, genes affecting carbohydrates or oils, and genes affecting carotenoids or other nutritional components produced in plants.
- expression of antisense genes may also be employed, such as ACC synthase, or genes conferring nematode resistance.
- the termination region or 3' non-translated region which is employed is one which will cause the termination of transcription and the addition of polyadenylated ribonucleotides to the 3' end of the transcribed mRNA sequence.
- the termination region or 3' non- translated region will be additionally one of convenience.
- the termination region may be native with the promoter region, native with the structural gene, or may be derived from another source, and preferably include a terminator and a sequence coding for polyadenylation.
- Suitable 3' non-translated regions of the chimeric plant gene include but are not limited to:
- Ti Agrobacterium tumor-inducing
- NOS nopahne synthase
- ssRUBISCO ribulose 1,5-bisphosphate carboxylase-oxygenase
- the various components of the expression construct or fragments thereof will normally be inserted into a convenient cloning vector which is capable of replication in a bacterial host, such as E. coli.
- a convenient cloning vector which is capable of replication in a bacterial host, such as E. coli.
- the vector may be isolated and subjected to further manipulation, such as restriction, insertion of new fragments, ligation, deletion, resection, insertion, in vitro mutagenesis, addition of polylinker fragments, and the like, in order to provide a vector which will meet a particular need.
- a variety of techniques are available for the introduction of the genetic material into or transformation of the plant cell host.
- the particular manner of introduction of the plant vector into the host is not critical to the practice of the present invention. Any method which provides for efficient transformation may be employed as is known and practiced by those of skill in the art.
- transformation using plant transformation vectors derived from the tumor-inducing (Ti) or root-inducing (Ri) plasmids of Agrobacterium could be used to insert the DNA constructs of the present invention into plant cells.
- Such methods may include, for example, the use of liposomes, electroporation, chemicals that increase the free uptake of DNA, DNA delivery via microprojectile bombardment, microinjection, and transformation using viruses or pollen.
- a plant transformation vector preferably includes all of the necessary elements for transformation of plant cells.
- Typical plant cloning vectors comprise selectable marker genes, scoreable marker genes, T-DNA borders, cloning sites, appropriate bacterial genes to facilitate the identification of transformants, broad host range replication and mobilization functions, and other elements as desired.
- the structural gene may be inserted into any suitable plant transformation vector for transformation into the desired plant species.
- Suitable plant transformation vectors include those derived from a Ti plasmid of Agrobacterium tumefaciens, in addition to those disclosed, for example, by Herrera-Estrella (1983), Bevan (1984), Klee (1985) and Fraley (1983).
- Selectable marker genes may be used to select for those cells which have become transformed.
- the marker employed may be resistance to an antibiotic, such as kanamycin, G418, hygromycin, streptomycin, and the like.
- Other markers could be employed in addition to or in the alternative, such as, for example, a gene coding for herbicide tolerance such as tolerance to glyphosate, sulfonylurea, phosphinothricin, or bromoxynil. Additional means of selection could also be employed.
- the particular marker employed will be one which will allow for the selection of transformed cells as opposed to those cells which were not transformed. Depending on the number of different host species one or more markers may be employed, where different conditions of selection would be used to select the different host, and would be known to those of skill in the art.
- Plant transformation vectors containing the 5' non-translated leader sequence which is operably linked to a structural gene may be used to transform plants of the Solanaceae family.
- An Agrobacterium- mediated transformation protocol is known to be effective in transforming members of the Solanaceae family.
- the desired transformation vector is mobilized into a suitable Agrobacterium strain.
- the ABI Agrobacterium strain is described for exemplary purposes.
- the desired transformation vector is mobilized into an ABI Agrobacterium strain by the triparental mating system using the helper plasmid pRK2013 (Ditta et al. 1980).
- the binary ABI strain is the chloramphenicol resistant derivative of Agrobacterium tumefaciens A208 which carries the disarmed Ti plasmid pTiC58 (Koncz and Schell 1986).
- the Ti plasmid does not carry the T-DNA phytohormone genes and the strain is therefore unable to cause crown gall disease.
- the disarmed Ti plasmid provides the trfA gene functions required for autonomous replication of the vector after conjugation into the ABI strain.
- the vector is transferred to the plant cells by the vir functions encoded by the disarmed pTiC58 plasmid.
- the pTiC58 Ti plasmid does not transfer to the plant cells, but remains in the Agrobacterium.
- Either single- or double-border transformation vectors can be delivered to the plant by Agrobacterium.
- Single border vectors open at the right T-DNA border region, and the entire vector sequence is inserted into the host plant chromosome. The right border is lost during transfer and integration.
- DNA between the right and left borders is inserted into the plant chromosome, thereby delivering only the chimeric genes of interest to the chromosome. The remainder of the vector, and the border sequences are lost during the transfer and integration.
- Transformation and regeneration protocols for members of the Solanaceae family are known in the art. After the tomato or potato plant has been transformed and after transformed callus has been identified, the transformed callus tissue is regenerated into whole plants. Any known method of regeneration of potato plants can be used in this invention. For tomato, the transformation protocol described in McCormick et al. (1986 ) may generally be employed. The regeneration of plants from either single plant protoplasts or various explants is well known in the art. See, for example, Methods for Plant Molecular Biology. A. Weissbach and H. Weissbach, eds., Academic Press, Inc., San Diego, CA (1988).
- This regeneration and growth process includes the steps of selection of transformant cells and shoots, rooting the transformant shoots and growth of the plantlets in soil.
- the regeneration of plants transformed by Agrobacterium from leaf explants can be achieved as described by Horsch et al, Science 227:1229-1231 (1985).
- transformants are grown in the presence of a selection agent and in a medium that induces the regeneration of shoots in the plant species being transformed as described by Fraley et al. , Proc. Nat'l. Acad. Sci. U.S.A.. 80:4803 (1983).
- This procedure typically produces shoots within 2 to 4 months and these transformant shoots are then transferred to an appropriate root-inducing medium containing the selective agent and an antibiotic to prevent bacterial growth.
- Transformant shoots that are rooted in the presence of the selective agent to form plantlets are then transplanted to soil or other media to ' allow the production of roots.
- the invention also provides plant cells, the genome of which comprises an expression cassette comprising the 5' non-translated leader sequence of the present invention, wherein said 5' non-translated leader sequence functions in such a way as to provide enhanced expression of the structural gene to which the 5' non-translated leader sequence is operably finked.
- Whole plants comprising such cells will have the features or benefits provided by the expression of the structural gene which is operably linked to said 5' non-translated leader sequence.
- Such plants may be monocots or dicots, and may include but are not limited to plants belonging to families selected from the group consisting of Solanaceae, Graminae, Cucurbitaceae, Caricaceae, Dioscoreacea, Leguminosae, Compositae, and Chenopodiaceae.
- a plant of the present invention containing the desired structural gene may be cultivated using methods known to those of skill in the art.
- a transformed plant of the present invention thus is capable of expressing the structural gene and exhibits the particular trait thereby.
- the presence of the particular structural gene or gene product in the transformed plant may be determined by any suitable method known to those of skill in the art. Included in these methods are Southern,
- the transformed plant capable of expressing the structural gene may then be assayed for the determination of the particular activity.
- the plasmid pMON755 is a pUC119 (Vieira and Messing 1987) based vector which contains the CaMV enhanced 35S promoter (e35S - Kay et al. 1987), the ⁇ - glucuronidase gene (GUS, pRAJ275, Clontech Laboratories, Inc.) and the nopaline synthase 3' termination sequence (NOS 3'- Fraley et al. 1983).
- pMON755 contains a Stul blunt end restriction enzyme site at the start of transcription from the CaMV promoter (Guilley et al.
- oligonucleotide was designed as complimentary pairs which when annealed would generate a blunt 5' end, and would generate a 5' overhang at the 3' end which is compatible with and can be ligated to a DNA fragment restricted with Ncol.
- Each leader was also synthesized to contain the four nucleotides AC AC at the 5' end. These four nucleotides are the naturally occurring bases downstream of the start of CaMV transcription (Guilley et al. 1982) and were provided with each oligonucleotide to provide similar sequence context at the start of transcription for each leader construct. Similarly, a consensus sequence was used at the 3' end of the oligonucleotide to provide similar and near optimum sequence context at the start of translation (Kozak 1986).
- Plasmid pMON755 was digested with Ncol (Boehringer Manheim) and Stul (New England Biolabs) according to manufacturer directions. Complimentary synthetic oligonucleotide pairs were annealed and subcloned into pMON755. Each vector was identical except for the leader sequence used.
- the soybean HSP17.9 heat shock leader was constructed from one complimentary oligonucleotide pair.
- the petunia and maize HSP70 leaders were constructed from two pairs of complimentary oligonucleotides. For either the maize or petunia HSP leaders, two oligonucleotides were synthesized and annealed to generate Fragment 1.
- Fragment 1 and Fragment 2 were ligated with previously digested pMON755 as described below. Ligations were performed using 25 pmol of each annealed oligonucleotide pair with 200 ngs of digested pMON755. Ligations were performed according to manufacturer's specifications (New England Biolabs). The E. coli host MM294 (Talmadge and Gilbert 1980) was rendered competent (Sambrook et al. 1989) and transformed with the ligation mix. Transformed cells were selected by plating the cells on LB media (Sambrook et al.
- TXD tobacco suspension cell protoplasts were electroporated with CsCl purified (Sambrook et al. 1989) plasmid DNA. Transformations were performed in triplicate and each transformation included an internal control plasmid.
- the control plasmid contained a different reporter gene and was used to correct for variability in the transformation and extraction procedures.
- luciferase expression vector pMON8796 was used as the internal control.
- Other published plant luciferase vectors such as pD0432 (Ow et al. 1986) or pCaMVLN (Callis et al. 1987) could be used.
- pMON8796 is a pUC119 derivative (Vieira and Messing 1987) similar to pMON755 containing the e35S CaMV promoter, the luciferase (LUX) gene (De Wet et al. 1987) and the NOS 3'.
- 25 ⁇ g of plasmid DNA was used with 5 ⁇ g of the internal control plasmid.
- TXD cells were grown in TXD media which contained 4.3 g 1 Murashige and Skoog salts (Gibco), 3% sucrose, 0.2 g/1 inositol, 0.13 g 1 asparagine, 4 ⁇ g/ml of PCPA( p-chlorophenoxyacetic acid), 5 ng/ml of kinetin, 1.3 mg/1 nicotinic acid, 0.25 mg/1 thiamine, 0.25 mg 1 pyridoxine HCL, and 0.25 mg 1 calcium pantothenate at a pH of 5.8. Fifty mis of TXD cells were maintained in a 250 ml flask, in the dark at 25°C, shaking at 140 rpm.
- the plates were parafilmed and incubated at 26-28°C on a rotary shaker at 50-60 rpm for one hour in the light. Digestion was monitored by observation through an inverted microscope. After digestion was complete the protoplasts were transferred back into 50 ml sterile centrifuge tubes using 10 ml pipettes with standard tips. The protoplasts were spun down at 200 x g for 5 minutes. The supernatant discarded and the protoplasts gently resuspended in 20 mis protoplast isolation media.
- the protoplasts were spun down and then resuspended in 20 mis of electroporation buffer (EB - 0.02 g 1 KH 2 P0 4 , 0.115 g/1 Na 2 HP0 4 , 7.5 g/1 NaCl, and 36.4 g/1 Mannitol pH 7.2). The protoplasts were counted using a hemocytometer and yields were determined. Protoplasts were spun down again and resuspended in EB to a density of 2x106 cells per ml and held on ice.
- electroporation buffer EB - 0.02 g 1 KH 2 P0 4 , 0.115 g/1 Na 2 HP0 4 , 7.5 g/1 NaCl, and 36.4 g/1 Mannitol pH 7.2.
- Electroporations were performed using a BioRad Gene Pulser® electroporation system (Gene Pulser and Capacitance Extender).
- Protoplasts (0.4 ml) were mixed with plasmid DNA (diluted to 0.4ml with EB) and added to a 0.8 ml cuvette (BioRad 0.4 cm gap).
- the protoplasts and DNA were mixed by gently inverting the cuvette twice and then electroporated at 150 volts at a capacitance of 500 ⁇ Farads.
- the transformed protoplasts were placed on ice for 10 minutes then allowed to warm to room temperature for 10 minutes.
- Protoplasts were resuspended in 7ml of TXD media containing 0.4M mannitol plus one- fifth volume of conditioning media (previously described) and transferred to 100 x 25mm petri dishes. The protoplasts were then incubated in light at 26-28°C. After 20-24 hours the protoplasts were collected by centrifugation and the media was removed. The pellet was resuspended in 250 ⁇ l extraction buffer (0.1M KP0 4 pH 7.8, lOmM DTT, lmM NaEDTA, 5% glycerol). Cells were lysed for assay by freeze-tha wing between dry ice and a 37°C water bath.
- GUS activity was determined from 5 ⁇ l of cell extract according to the methods of Jefferson et al. (1987) using 2 mM MUG in the previously described extraction buffer. Fluorescence was measured using a Hoescht DNA Fluorometer (Model TKO 100). A methylumbelliferone (Sigma) standard curve was generated using a l ⁇ m solution. GUS activity was calculated as pmol MU/minute/ml extract.
- luciferase activity was calculated as the average relative light units/ml extract.
- the level of gene expression using a heat shock leader sequence was greater than expression levels from the previously described viral leader sequences (Skuzeski et al. 1990).
- a series of vectors were constructed which contained 5' leader sequence fusions to the luciferase, ACC deaminase, and the Bacillus thuringinesis v. kurstaki coding sequences (Ow et al. 1986, Klee et al. 1991, and Wong et al. 1992, respectively).
- the GUS coding sequence was replaced with the luciferase coding sequence from pMON772.
- the luciferase coding sequence was subcloned as a Ncol to BamHl fragment using standard digestion and ligation protocols. Similarily, the B.t.k. expression plasmids were constructed using a Ncol/BamHl fragment isolated from pMON10871.
- the ACC deaminase expression vectors were constructed as follows: Plasmid pMON 10866, which contains the P-FMV GUS NOS 3' gene, was digested with the restriction endonucleases Stul and Bgl2. New heat shock and control leader oligonucleotides were synthesized and subcloned into the digested pMON10866.
- ACC deaminase evaluations were performed using the tobacco protoplast transient assay. Electroporated protoplasts were resuspended in 0.4 ml 0.1 M Tris-HCl pH7.8, 5mM Na 2 EDTA, lOmM DTT and 10 % glycerol. Cells were extracted by freeze-thaw as previously described. ACC deaminase activity was determined by quantitating levels of alpha-ketobutryate following incubation of the enzyme with the substrate ACC (Honma and Shimomura, 1978).
- 0.05ml of tobacco cell extract was added to 0.05ml of a solution containing 0.2 M Tris-HCl pH 7.8 and 0.1 M amino cyclopropane- 1- carboxylic acid (ACC).
- ACC cyclopropane- 1- carboxylic acid
- This reaction mix was incubated at 37° C for 30 minutes and then terminated with the addition of 0.9ml of 0.56N HC1.
- To this solution was added 0.15 ml of 0.1% dinitrophenyl hydrazine in 2N HC1.
- the samples were then incubated for 15 minutes at 25°C. Following this period, 1.0 ml of 2N NaOH was added to the samples. Samples were allowed to sit for 15 minutes at 25°C to allow the color to stabilize, then were measured for absorbance at O.D. 540 using a spectrophotometer.
- luciferase vector pMON8796 was used as the internal control for the ACC deaminase electroporations.
- ACC deaminase transient assay results are presented as the average of 4 electroporations and are shown in Table 3 below:
- the tobacco transient assays was also used for evaluating the 5' leader effect on expression of the B.t.k. gene.
- the luciferase expressing plasmid pMON772 was included as an internal control. Luciferase expression levels were used to standardize loadings for western analysis of the B.t.k. protein.
- the electroporated protoplast were resuspended in extraction buffer (0.1M KP0 4 , 5% glycerol, ImM EDTA, lOmM DTT). One half of the resuspended cells were used for luciferase assays using the procedure previously described.
- the primary B.t.k. antibody was bound by incubating the membrane in a 1:2000 dilution of the rabbit serum in TBST for 18 hr. This was followed by three 10-min washes in TBST.
- the secondary reagent was bound by incubating the membrane with 5 ⁇ C of I2 ⁇ l-labelled protein G in 20 ml of TBST for 30 min. The membrane was washed three times for 10 min each with 0.3% Triton X-100 followed by three washings 0.1% Triton X-100 and then exposed to film. Levels of protein expression were determined using a densitometer. Results are as follows:
- a maize heat shock 5' leader was tested for its effect on maize gene expression.
- the maize HSP70 leader was subcloned as synthetic oligonucleotides in an identical fashion to the dicot leader sequences.
- the maize HSP70 leader was fused with the GUS and luciferase coding sequences. Leader sequence analysis was performed in a monocot transient assay system.
- Maize BMS Black Mexican Sweet- ATCC #54022 suspension cell protoplasts were transformed with the maize HSP70 leader constructs and with the previously described viral leader sequence constructs. Maize BMS cells were maintained and prepared for protoplast transformation as described by Fromm (Fromm et al. 1987) with the following exceptions.
- the BMS media used was as follows, MS salts (Gibco),_2 mg/L 2,4-D, 0.25mg/L thiamine HC1, lmM asparagine, 20g/L sucrose, lOOmg/L inositol, 1.3mg/L nicotinic acid, 0.25mg/L pyridoxine HC1 and calcium pantothenate, pH 5.8.
- BMS lines were subcultured every other day by transfer of 25mls suspended cells into 40mls liquid media in 250mls Erlenmeyer flasks. Lines were maintained in the dark or very low light, at 28°C, and at a shaker speed of 120-150 rpm. Protoplasts were isolated one day following subculturing (Fromm et al. 1987). One gram of fresh cell weight of BMS cells was digested with 10 mis of enzyme mixture. A protoplast concentration of 3 x 106 cells /ml was used for the electroporation. Electroporations were performed as described for tobacco. Following electroporation cells were placed on ice for 10 minutes then transferred to a 100 x 25 mm petri dish and allowed to sit at room temperature for 10 minutes.
- Firefly luciferase gene structure and expression in mammalian cells. Mol. and Cell. Biol. 7, 725-737.
- GUS fusions ⁇ -glucuronidase as a sensitive and versatile gene fusion marker in higher plants. EMBO 6, 3901-3907.
- Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44, 283-292.
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
- MOLECULE TYPE DNA (genomic)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cultivation Of Plants (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/117,374 US5362865A (en) | 1993-09-02 | 1993-09-02 | Enhanced expression in plants using non-translated leader sequences |
| US117374 | 1993-09-02 | ||
| PCT/US1994/010256 WO1995006742A1 (en) | 1993-09-02 | 1994-09-01 | Enhanced expression in plants using non-translated leader sequences |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0716709A1 true EP0716709A1 (en) | 1996-06-19 |
| EP0716709B1 EP0716709B1 (en) | 2009-02-18 |
Family
ID=22372557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP94929179A Expired - Lifetime EP0716709B1 (en) | 1993-09-02 | 1994-09-01 | Enhanced expression in plants using non-translated leader sequences |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US5362865A (en) |
| EP (1) | EP0716709B1 (en) |
| AT (1) | ATE423213T1 (en) |
| AU (1) | AU7833494A (en) |
| CA (1) | CA2169854C (en) |
| DE (1) | DE69435187D1 (en) |
| WO (1) | WO1995006742A1 (en) |
Families Citing this family (174)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5362865A (en) * | 1993-09-02 | 1994-11-08 | Monsanto Company | Enhanced expression in plants using non-translated leader sequences |
| US5824497A (en) * | 1995-02-10 | 1998-10-20 | Mcmaster University | High efficiency translation of mRNA molecules |
| US6020154A (en) * | 1995-04-20 | 2000-02-01 | Board Of Regents, The University Of Texas System | H. influenzae HxuB and HxuC genes, proteins and methods of use |
| US5723755A (en) * | 1995-05-16 | 1998-03-03 | Francis E. Lefaivre | Large scale production of human or animal proteins using plant bioreactors |
| US6602657B1 (en) * | 1995-12-28 | 2003-08-05 | Tropix, Inc. | Multiple reporter gene assay |
| US5876995A (en) | 1996-02-06 | 1999-03-02 | Bryan; Bruce | Bioluminescent novelty items |
| US6247995B1 (en) | 1996-02-06 | 2001-06-19 | Bruce Bryan | Bioluminescent novelty items |
| US5850019A (en) * | 1996-08-06 | 1998-12-15 | University Of Kentucky Research Foundation | Promoter (FLt) for the full-length transcript of peanut chlorotic streak caulimovirus (PCLSV) and expression of chimeric genes in plants |
| US6416960B1 (en) | 1996-08-08 | 2002-07-09 | Prolume, Ltd. | Detection and visualization of neoplastic tissues and other tissues |
| JP3795533B2 (en) | 1996-12-12 | 2006-07-12 | プロルーム・リミテツド | Method and apparatus for detecting and identifying infectious substances |
| US7022896B1 (en) | 1997-04-04 | 2006-04-04 | Board Of Regents Of University Of Nebraska | Methods and materials for making and using transgenic dicamba-degrading organisms |
| US7105724B2 (en) | 1997-04-04 | 2006-09-12 | Board Of Regents Of University Of Nebraska | Methods and materials for making and using transgenic dicamba-degrading organisms |
| DE69841807D1 (en) | 1997-11-06 | 2010-09-16 | Novartis Vaccines & Diagnostic | NEISSERIAL ANTIGENE |
| DE69941567D1 (en) | 1998-01-14 | 2009-12-03 | Novartis Vaccines & Diagnostic | ANTIGENE FROM NEISSERIA MENINGITIDIS |
| WO1999049019A2 (en) | 1998-03-27 | 1999-09-30 | Prolume, Ltd. | Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| DE69937419T2 (en) | 1998-05-01 | 2008-07-24 | Novartis Vaccines and Diagnostics, Inc., Emeryville | Neisseria meningitidis antigens and compilations |
| WO2000011200A2 (en) * | 1998-08-19 | 2000-03-02 | Monsanto Company | Plant expression vectors |
| US6489542B1 (en) * | 1998-11-04 | 2002-12-03 | Monsanto Technology Llc | Methods for transforming plants to express Cry2Ab δ-endotoxins targeted to the plastids |
| US20080000405A1 (en) | 2006-06-23 | 2008-01-03 | Wei Wu | S-adenosylmethionine Synthetase Expression Elements Identified from Arabidopsis thaliana |
| GB9828660D0 (en) | 1998-12-24 | 1999-02-17 | Cambridge Advanced Tech | Control of gene expression in eukaryotes |
| GB9905498D0 (en) * | 1999-03-11 | 1999-05-05 | Glaxo Group Ltd | Expression |
| US7368261B1 (en) | 1999-04-30 | 2008-05-06 | Novartis Vaccines And Diagnostics Srl | Conserved Neisserial antigens |
| US10329575B2 (en) | 1999-05-14 | 2019-06-25 | Ceres, Inc. | Regulatory sequence for plants |
| US8877916B2 (en) | 2000-04-26 | 2014-11-04 | Ceres, Inc. | Promoter, promoter control elements, and combinations, and uses thereof |
| US9029523B2 (en) * | 2000-04-26 | 2015-05-12 | Ceres, Inc. | Promoter, promoter control elements, and combinations, and uses thereof |
| GB9911683D0 (en) | 1999-05-19 | 1999-07-21 | Chiron Spa | Antigenic peptides |
| US6395962B1 (en) | 1999-06-22 | 2002-05-28 | University Of South Carolina | Enhancing expression of a silenced target sequence in plants using plant viral enhancers and amplicons |
| GB9916529D0 (en) | 1999-07-14 | 1999-09-15 | Chiron Spa | Antigenic peptides |
| US7547774B2 (en) * | 1999-07-20 | 2009-06-16 | Monsanto Technology Llc | RCc3 regulatory elements for use in plants |
| US7365185B2 (en) * | 2000-07-19 | 2008-04-29 | Monsanto Technology Llc | Genomic plant sequences and uses thereof |
| PT2275554E (en) | 1999-10-29 | 2015-06-26 | Novartis Vaccines & Diagnostic | Neisserial antigenic peptides |
| HK1046016B (en) | 1999-11-12 | 2009-02-27 | Fibrogen, Inc. | Recombinant gelatin in vaccines |
| TR200201588T2 (en) | 1999-12-16 | 2002-10-21 | Monsanto Technology Llc | New plant definition structures |
| EP2275129A3 (en) | 2000-01-17 | 2013-11-06 | Novartis Vaccines and Diagnostics S.r.l. | Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins |
| US7109315B2 (en) | 2000-03-15 | 2006-09-19 | Bruce J. Bryan | Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| BR122013026754B1 (en) * | 2000-06-22 | 2018-02-27 | Monsanto Company | DNA Molecule And Processes To Produce A Corn Plant Tolerant For Glyphosate Herbicide Application |
| AU1412702A (en) | 2000-10-27 | 2002-05-06 | Chiron Spa | Nucleic acids and proteins from streptococcus groups a and b |
| GB0107658D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
| GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| ATE530654T1 (en) | 2001-07-06 | 2011-11-15 | Monsanto Technology Llc | METHOD FOR PROMOTING THE SEPARATION OF TRANSGENES IN PLANTS AND COMPOSITIONS THEREFOR |
| JPWO2003009660A1 (en) * | 2001-07-18 | 2004-11-11 | 松下電器産業株式会社 | Method for manufacturing circuit-formed substrate and material for manufacturing circuit-formed substrate |
| WO2003014348A1 (en) * | 2001-08-06 | 2003-02-20 | Monsanto Technology Llc | Dna molecules from maize and methods of use thereof |
| ES2312649T3 (en) | 2001-12-12 | 2009-03-01 | Novartis Vaccines And Diagnostics S.R.L. | IMMUNIZATION AGAINST CHLAMYDIA TRACHOMATIS. |
| EP2216405A1 (en) | 2002-05-03 | 2010-08-11 | Monsanto Technology LLC | Speed specific USP promoters for expressing genes in plants |
| CA2490274A1 (en) * | 2002-06-27 | 2004-01-08 | Dow Agrosciences Llc | Use of regulatory sequences in transgenic plants |
| PT2279746E (en) | 2002-11-15 | 2013-12-09 | Novartis Vaccines & Diagnostic | Surface proteins in neisseria meningitidis |
| EP1587931B1 (en) | 2003-01-31 | 2012-04-11 | Monsanto Technology LLC | Glyphosate tolerant alfalfa events and methods for detection thereof |
| CA2519912A1 (en) | 2003-03-28 | 2004-10-14 | Monsanto Technology Llc | Regulatory regions that promote early plant seed enhanced transcription |
| GB0308198D0 (en) | 2003-04-09 | 2003-05-14 | Chiron Srl | ADP-ribosylating bacterial toxin |
| US7514533B2 (en) * | 2003-05-21 | 2009-04-07 | Ares Trading S.A. | TNF-like secreted protein |
| PL2343364T3 (en) | 2003-08-25 | 2017-07-31 | Monsanto Technology Llc | Tubulin regulatory elements for use in plants |
| US20060021083A1 (en) * | 2004-04-01 | 2006-01-26 | Zhihong Cook | Promoter, promoter control elements, and combinations, and uses thereof |
| US11634723B2 (en) | 2003-09-11 | 2023-04-25 | Ceres, Inc. | Promoter, promoter control elements, and combinations, and uses thereof |
| US20130117881A1 (en) | 2003-10-14 | 2013-05-09 | Ceres, Inc. | Promoter, promoter control elements, and combinations, and uses thereof |
| US7402667B2 (en) * | 2003-10-14 | 2008-07-22 | Ceres, Inc. | Promoter, promoter control elements, and combinations, and uses thereof |
| US11739340B2 (en) | 2003-09-23 | 2023-08-29 | Ceres, Inc. | Promoter, promoter control elements, and combinations, and uses thereof |
| WO2005060664A2 (en) | 2003-12-10 | 2005-07-07 | Monsanto Technology Llc | Stress tolerant plants and methods thereof |
| EP1718663B1 (en) * | 2004-01-20 | 2011-07-13 | Monsanto Technology, LLC | Chimeric promoters for use in plants |
| US20070006335A1 (en) * | 2004-02-13 | 2007-01-04 | Zhihong Cook | Promoter, promoter control elements, and combinations, and uses thereof |
| BRPI0514473A (en) * | 2004-08-19 | 2008-06-10 | Monsanto Technology Llc | eukaryotic translation initiation factor gene regulatory elements for use in plants |
| WO2006023869A2 (en) | 2004-08-24 | 2006-03-02 | Monsanto Technology Llc | Adenylate translocator protein gene non-coding regulatory elements for use in plants |
| CA2580201A1 (en) * | 2004-09-14 | 2006-03-23 | Monsanto Technology Llc | Promoter molecules for use in plants |
| GB0423126D0 (en) * | 2004-10-18 | 2004-11-17 | Ares Trading Sa | Protein |
| GB0426960D0 (en) * | 2004-12-08 | 2005-01-12 | Ares Trading Sa | TGR-3 like protein receptor |
| US7408055B2 (en) * | 2005-02-10 | 2008-08-05 | Monsanto Technology Llc | Promoter molecules for use in plants |
| GB0504767D0 (en) * | 2005-03-08 | 2005-04-13 | Ares Trading Sa | Lipocalin protein |
| CN105017423B (en) | 2005-08-11 | 2019-06-04 | 阿皮·马托西安-罗杰斯 | TCR-V- β related peptides for treatment and diagnosis of autoimmune diseases |
| CN101321873B (en) | 2005-10-03 | 2013-08-14 | 孟山都技术有限公司 | Transgenic plant seed with increased lysine |
| WO2007120989A2 (en) * | 2006-02-24 | 2007-10-25 | Ceres, Inc. | Shade regulatory regions |
| BR122016030514B1 (en) | 2006-05-12 | 2019-04-16 | Monsanto Technology Llc | DNA constructs to obtain marker-free transgenic plants |
| CN101490266B (en) | 2006-05-16 | 2012-06-27 | 孟山都技术有限公司 | Use of non-agrobacterium bacterial species for plant transformation |
| CA2909340C (en) | 2006-05-25 | 2019-07-02 | Monsanto Technology Llc | A method to identify disease resistant quantitative trait loci in soybean and compositions thereof |
| UA98770C2 (en) | 2006-05-26 | 2012-06-25 | Монсанто Текнолоджи, Ллс | Corn plant and seeds corresponding to trangenic event mon89034, and methods for its determination and using |
| CA2653742C (en) | 2006-06-06 | 2016-01-05 | Monsanto Technology Llc | Method for selection of plant cells transformed with a polynucleotide encoding dicamba monooxygenase using auxin-like herbicides |
| US7855326B2 (en) * | 2006-06-06 | 2010-12-21 | Monsanto Technology Llc | Methods for weed control using plants having dicamba-degrading enzymatic activity |
| ATE522541T1 (en) | 2006-06-09 | 2011-09-15 | Novartis Ag | BACTERIAL ADHESIN CONFORMERS |
| AU2007272314B2 (en) * | 2006-07-12 | 2014-05-01 | Commonwealth Scientific And Industrial Research Organisation | Polynucleotides and methods for enhancing salinity tolerance in plants |
| MX2009002250A (en) | 2006-08-31 | 2009-03-16 | Monsanto Technology Llc | Methods for rapidly transforming monocots. |
| EP2053916A2 (en) | 2006-10-16 | 2009-05-06 | Monsanto Technology, LLC | Methods and compositions for improving plant health |
| US7939721B2 (en) | 2006-10-25 | 2011-05-10 | Monsanto Technology Llc | Cropping systems for managing weeds |
| ITUD20060280A1 (en) * | 2006-12-29 | 2008-06-30 | Univ Degli Studi Udine | ARTIFICIAL SEQUENCE OF DNA EVENT FUNCTION OF LEADER IN 5 '(5'-UTR) OPTIMIZED FOR THE OVEREXPRESSION OF HETEROLOGICAL PLANT PROTEINS |
| US7838729B2 (en) | 2007-02-26 | 2010-11-23 | Monsanto Technology Llc | Chloroplast transit peptides for efficient targeting of DMO and uses thereof |
| EP2425709B1 (en) | 2007-03-09 | 2017-11-15 | Monsanto Technology, LLC | Preparation and use of plant embryo explants for transformation |
| AU2008271907A1 (en) * | 2007-06-29 | 2009-01-08 | Commonwealth Scientific And Industrial Research Organisation | Methods for degrading toxic compounds |
| US8642846B2 (en) | 2007-08-13 | 2014-02-04 | Commonwealth Scientific And Industrial Research Organisation | Barley with low levels of hordeins |
| GB0724532D0 (en) * | 2007-12-17 | 2008-01-30 | Nat Univ Ireland | Trail variants for treating cancer |
| WO2009146015A2 (en) | 2008-03-31 | 2009-12-03 | Ceres, Inc. | Promoter, promoter control elements, and combinations, and uses thereof |
| CN103333894B (en) | 2008-04-07 | 2016-11-23 | 孟山都技术公司 | Plant control element and application thereof |
| WO2009129582A1 (en) * | 2008-04-25 | 2009-10-29 | Commonwealth Scientific Industrial Research Organisation | Polypeptides and methods for producing triacylglycerols comprising modified fatty acids |
| US20110126325A1 (en) * | 2008-04-25 | 2011-05-26 | Commonwealth Scientific Industrial Research Organisation | Recombinant cells and methods for hydroxylating fatty acids |
| US8536406B2 (en) * | 2008-04-28 | 2013-09-17 | Michigan Technological University | COMT1 gene fiber-specific promoter elements from poplar |
| US8419145B2 (en) * | 2008-07-25 | 2013-04-16 | Eastman Kodak Company | Inkjet printhead and method of printing with multiple drop volumes |
| CN114045301A (en) | 2008-11-18 | 2022-02-15 | 联邦科学技术研究组织 | Enzymes and methods for producing omega-3 fatty acids |
| WO2010060609A1 (en) | 2008-11-26 | 2010-06-03 | Bayer Bioscience N.V. | Expression cassettes for seed-specific expression in plants |
| AU2010268400A1 (en) | 2009-07-01 | 2012-02-02 | Bayer Cropscience Nv. | Methods and means for obtaining plants with enhanced glyphosate tolerance |
| EP2333074A1 (en) | 2009-12-14 | 2011-06-15 | Robert Steinfeld | Substances and methods for the treatment of lysosmal storage diseases |
| EP2521439A4 (en) * | 2010-01-05 | 2013-05-15 | Syngenta Participations Ag | SYNTHETIC CONSTITUENT PLANT PROMOTERS AND METHODS OF USING SAME |
| EP2524045B1 (en) | 2010-01-14 | 2015-12-02 | Monsanto Technology LLC | Plant regulatory elements and uses thereof |
| US9695432B2 (en) | 2010-01-22 | 2017-07-04 | Dow Agrosciences Llc | Excision of transgenes in genetically modified organisms |
| CA2804025C (en) | 2010-06-28 | 2023-02-21 | Commonwealth Scientific And Industrial Research Organisation | Methods of producing lipids |
| SI2611925T1 (en) | 2010-08-30 | 2018-04-30 | Dow Agrosciences, Llc | Sugarcane bacilliform viral (scbv) enhancer and its use in plant functional genomics |
| EP2651207B1 (en) | 2010-12-17 | 2017-11-08 | Monsanto Technology LLC | Methods for improving competency of plant cells |
| MX353321B (en) | 2010-12-30 | 2018-01-05 | Dow Agrosciences Llc | Nucleic acid molecules that target the vacuolar atpase c subunit and confer resistance to coleopteran pests. |
| AU2011352005B2 (en) | 2010-12-30 | 2017-03-16 | Dow Agrosciences Llc | Nucleic acid molecules that confer resistance to coleopteran pests |
| UY33853A (en) | 2010-12-30 | 2012-07-31 | Dow Agrosciences Llc | ? NUCLEIC ACID MOLECULES THAT ARE DIRECTED TO SUBUNITY H OF THE VACUOLAR ATPASA AND CONFERENCE RESISTANCE TO PATHOPHERAL PESTS ?. |
| EP2661498B1 (en) | 2011-01-04 | 2016-11-30 | Bayer CropScience NV | Fiber selective promoters |
| EP2668278A1 (en) | 2011-01-24 | 2013-12-04 | Bayer CropScience NV | Use of the rd29 promoter or fragments thereof for stress-inducible expression of transgenes in cotton |
| WO2012134921A2 (en) | 2011-03-25 | 2012-10-04 | Monsanto Technology Llc | Plant regulatory elements and uses thereof |
| CN103443280B (en) | 2011-04-07 | 2017-06-30 | 拜尔作物科学公司 | Seed specific promoters in cotton |
| CN106947765B (en) | 2011-05-13 | 2020-10-02 | 孟山都技术公司 | Plant regulatory elements and their applications |
| WO2013010225A1 (en) | 2011-07-20 | 2013-01-24 | Commonwealth Scientific And Industrial Research Organisation | Enzymes for degrading organophosphates |
| EP2742059A1 (en) | 2011-08-12 | 2014-06-18 | Bayer CropScience NV | Guard cell-specific expression of transgenes in cotton |
| BR122014004140B8 (en) | 2011-08-22 | 2023-03-28 | Bayer Cropscience Ag | RECOMBINANT VECTOR OR RECOMBINANT CONSTRUCTION, AS WELL AS METHODS FOR OBTAINING AND PRODUCING A COTTON PLANT OR PLANT CELL TOLERANT TO AN HPPD INHIBITOR, AND FOR CULTIVATING A FIELD OF COTTON PLANTS |
| BR112014008723A2 (en) | 2011-10-12 | 2019-09-24 | Bayer Cropscience Ag | plants with decreased activity of a starch dephorylation enzyme |
| BR112014008895A2 (en) | 2011-10-12 | 2019-09-24 | Bayer Cropscience Ag | plants with decreased activity of a starch dephosphorylation enzyme |
| DK2798065T3 (en) | 2011-12-27 | 2019-09-16 | Commw Scient Ind Res Org | SIMILAR REINACTIVATION AND SUPPRESSION OF GENINACTIVATION IN THE SAME CELL |
| PH12021552871A1 (en) | 2011-12-27 | 2022-09-28 | Commw Scient Ind Res Org | Processes for producing lipids |
| WO2013096991A1 (en) | 2011-12-27 | 2013-07-04 | Commonwealth Scientific And Industrial Research Organisation | Production of dihydrosterculic acid and derivatives thereof |
| CA2863201A1 (en) | 2012-02-01 | 2013-08-08 | Dow Agrosciences Llc | Glyphosate resistant plants and associated methods |
| KR102076716B1 (en) | 2012-02-02 | 2020-02-13 | 다우 아그로사이언시즈 엘엘씨 | Plant transactivation interaction motifs and uses thereof |
| AR090204A1 (en) | 2012-02-29 | 2014-10-29 | Dow Agrosciences Llc | BACILIFORM VIRAL BOX OF SUGAR CANE (SCBV) AND ITS USE IN THE FUNCTIONAL GENOMICS OF PLANTS |
| AU2013205557B2 (en) | 2012-04-17 | 2016-04-21 | Corteva Agriscience Llc | Synthetic brassica-derived chloroplast transit peptides |
| US9663793B2 (en) | 2012-04-20 | 2017-05-30 | Monsanto Technology, Llc | Plant regulatory elements and uses thereof |
| PT2861059T (en) | 2012-06-15 | 2017-08-08 | Grains Res & Dev Corp | PRODUCTION OF LONG STRANDED POLYNATURATED FATTY ACIDS IN VEGETABLE CELLS |
| IN2014KN02929A (en) | 2012-07-06 | 2015-05-08 | Novartis Ag | |
| HK1217732A1 (en) | 2012-09-07 | 2017-01-20 | 美国陶氏益农公司 | Fad3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks |
| UA118090C2 (en) | 2012-09-07 | 2018-11-26 | ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі | Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks |
| AU2014211570A1 (en) | 2013-01-29 | 2015-07-23 | The University Court Of The University Of Glasgow | Methods and means for increasing stress tolerance and biomass in plants |
| US20140245475A1 (en) | 2013-02-27 | 2014-08-28 | Bayer Cropscience Lp | Cotton variety st 4946glb2 |
| WO2014197943A1 (en) | 2013-06-13 | 2014-12-18 | Commonwealth Scientific And Industrial Research Organisation | Barley with very low levels of hordeins |
| CA2917105C (en) | 2013-07-01 | 2023-09-26 | Bayer Cropscience Nv | Methods and means for modulating flowering time in monocot plants |
| WO2015044209A1 (en) | 2013-09-24 | 2015-04-02 | Bayer Cropscience Nv | Hetero-transglycosylase and uses thereof |
| WO2015089587A1 (en) | 2013-12-18 | 2015-06-25 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising long chain polyunsaturated fatty acids |
| WO2015095750A1 (en) | 2013-12-20 | 2015-06-25 | Dow Agrosciences Llc | Rnapii-140 nucleic acid molecules that confer resistance to coleopteran pests |
| BR102014031844A2 (en) | 2013-12-20 | 2015-10-06 | Dow Agrosciences Llc | RAS and related nucleic acid molecules that confer resistance to Coleoptera and Hemiptera pests |
| UY36030A (en) | 2014-03-12 | 2015-10-30 | Univ Sydney | "RNA PRODUCTION IN SUPERIOR PLANTS". |
| US10435687B2 (en) | 2014-05-07 | 2019-10-08 | Dow Agrosciences Llc | Nucleic acid molecules that confer resistance to coleopteran pests |
| PH12016502586B1 (en) | 2014-06-27 | 2023-07-19 | Commw Scient Ind Res Org | Lipid comprising docosapentaenoic acid |
| CA2954203C (en) | 2014-07-07 | 2023-12-05 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing industrial products from plant lipids |
| WO2016014720A2 (en) | 2014-07-22 | 2016-01-28 | Nmc, Inc. | Improved carbon fixation systems in plants and algae |
| WO2016050512A1 (en) | 2014-10-03 | 2016-04-07 | Bayer Cropscience Nv | Methods and means for increasing stress tolerance and biomass in plants |
| EP3218497A1 (en) | 2014-11-12 | 2017-09-20 | NMC Inc. | Transgenic plants with engineered redox sensitive modulation of photosynthetic antenna complex pigments and methods for making the same |
| US20160194658A1 (en) | 2014-12-22 | 2016-07-07 | Dow Agrosciences Llc | Nucampholin nucleic acid molecules to control coleopteran insect pests |
| WO2016113333A1 (en) | 2015-01-16 | 2016-07-21 | Bayer Cropscience Nv | Leaf-preferential promoters and uses thereof |
| WO2016128519A1 (en) | 2015-02-12 | 2016-08-18 | Bayer Cropscience Nv | Shoot apex-preferential promoters and uses thereof |
| US20160264991A1 (en) | 2015-03-13 | 2016-09-15 | Dow Agrosciences Llc | Rna polymerase i1 nucleic acid molecules to control insect pests |
| WO2016154631A1 (en) | 2015-03-26 | 2016-09-29 | The Texas A&M University System | Conversion of lignin into bioplastics and lipid fuels |
| BR102016012010A2 (en) | 2015-05-29 | 2020-03-24 | Dow Agrosciences Llc | NUCLEIC ACID, RIBONUCLEIC ACID (RNA) AND DOUBLE-FILAMENT RIBONUCLEIC ACID (DSRNA) MOLECULE, CELL, PLANT AND SEED USES, PRIMARY PRODUCT, AS WELL AS METHODS TO CONTROL A POPULATION OF HOLIDAYS, OR HOSPITALS, OR HOSPITALS, OR HOSPITALS, OR HOSPITALS THE INCOME OF A CULTURE, AND TO PRODUCE A TRANSGENIC VEGETABLE CELL AND A TRANSGENIC PLANT |
| CN114032251A (en) | 2015-08-07 | 2022-02-11 | 拜尔作物科学公司 | Root-preferred and stress-inducible promoters and uses thereof |
| DK3341483T3 (en) | 2015-08-28 | 2020-03-16 | Pioneer Hi Bred Int | OCHROBACTRUM-MEDIATED TRANSFORMATION OF PLANTS |
| US11913166B2 (en) | 2015-09-21 | 2024-02-27 | Modern Meadow, Inc. | Fiber reinforced tissue composites |
| EP3356537B1 (en) | 2015-10-02 | 2022-08-17 | Monsanto Technology LLC | Recombinant maize b chromosome sequence and uses thereof |
| US11525042B2 (en) | 2016-02-15 | 2022-12-13 | Modern Meadow, Inc. | Composite biofabricated material |
| CA3019984A1 (en) | 2016-04-11 | 2017-10-19 | Bayer Cropscience Nv | Seed-specific and endosperm-preferential promoters and uses thereof |
| WO2017178322A1 (en) | 2016-04-11 | 2017-10-19 | Bayer Cropscience Nv | Seed-specific and endosperm-preferential promoters and uses thereof |
| AU2017249366A1 (en) | 2016-04-13 | 2018-10-25 | Bayer Cropscience Nv | Seed-specific and embryo-preferential promoters and uses thereof |
| WO2017178367A1 (en) | 2016-04-13 | 2017-10-19 | Bayer Cropscience Nv | Seed- and funiculus-preferential promoters and uses thereof |
| WO2018005491A1 (en) | 2016-06-28 | 2018-01-04 | Monsanto Technology Llc | Methods and compositions for use in genome modification in plants |
| US20190225974A1 (en) | 2016-09-23 | 2019-07-25 | BASF Agricultural Solutions Seed US LLC | Targeted genome optimization in plants |
| EP3342780A1 (en) | 2016-12-30 | 2018-07-04 | Dow AgroSciences LLC | Pre-mrna processing factor 8 (prp8) nucleic acid molecules to control insect pests |
| AU2018239406A1 (en) | 2017-03-23 | 2019-09-26 | Basf Se | Anther-specific promoter and uses thereof |
| MX2019012525A (en) | 2017-04-19 | 2019-12-05 | Glaxosmithkline Biologicals Sa | CYTOMEGALOVIRUS PROTEINS MODIFIED AND STABILIZED COMPLEXES. |
| US11845944B2 (en) | 2017-05-24 | 2023-12-19 | Centre National De La Recherche Scientifique | Fungal rust-inducible promoter |
| CA3008850A1 (en) | 2017-06-29 | 2018-12-29 | Modern Meadow, Inc. | Yeast strains and methods for producing collagen |
| BR112020004747A2 (en) | 2017-09-13 | 2020-09-24 | Sanofi Pasteur | immunogenic composition of human cytomegalovirus |
| AU2018253595A1 (en) | 2017-11-13 | 2019-05-30 | Modern Meadow, Inc. | Biofabricated leather articles having zonal properties |
| US20200332311A1 (en) | 2018-01-12 | 2020-10-22 | The Texas A&M University System | Increasing plant bioproduct yield |
| WO2020079586A1 (en) | 2018-10-17 | 2020-04-23 | Glaxosmithkline Biologicals Sa | Modified cytomegalovirus proteins and stabilized complexes |
| CA3121853C (en) | 2019-01-17 | 2025-04-08 | Modern Meadow, Inc. | Layered collagen materials and methods of making the same |
| WO2022090359A1 (en) | 2020-10-28 | 2022-05-05 | Sanofi Pasteur | Liposomes containing tlr4 agonist, preparation and uses thereof |
| AU2023302130A1 (en) | 2022-07-05 | 2025-01-09 | University Of Freiburg | Plant regulatory elements and uses thereof |
| US20240093220A1 (en) | 2022-09-09 | 2024-03-21 | Friedrich Alexander Universität Erlangen-Nürnberg | Plant regulatory elements and uses thereof |
| WO2024099765A2 (en) | 2022-11-10 | 2024-05-16 | BASF Agricultural Solutions Seed US LLC | Transcription regulating nucleotide sequences and methods of use |
| US20250075226A1 (en) | 2023-08-29 | 2025-03-06 | University Of Freiburg | Proteins for regulation of symbiotic infection and associated regulatory elements |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0699757A1 (en) * | 1988-08-19 | 1996-03-06 | Asgrow Seed Company | Potyvirus coat protein genes and plants transformed therewith |
| EP0418695A1 (en) * | 1989-09-13 | 1991-03-27 | Ciba-Geigy Ag | Regulatory DNA sequence |
| US5187267A (en) * | 1990-06-19 | 1993-02-16 | Calgene, Inc. | Plant proteins, promoters, coding sequences and use |
| US5362865A (en) * | 1993-09-02 | 1994-11-08 | Monsanto Company | Enhanced expression in plants using non-translated leader sequences |
-
1993
- 1993-09-02 US US08/117,374 patent/US5362865A/en not_active Expired - Lifetime
-
1994
- 1994-07-25 US US08/280,263 patent/US5659122A/en not_active Expired - Lifetime
- 1994-09-01 EP EP94929179A patent/EP0716709B1/en not_active Expired - Lifetime
- 1994-09-01 CA CA002169854A patent/CA2169854C/en not_active Expired - Lifetime
- 1994-09-01 WO PCT/US1994/010256 patent/WO1995006742A1/en not_active Ceased
- 1994-09-01 DE DE69435187T patent/DE69435187D1/en not_active Expired - Lifetime
- 1994-09-01 AT AT94929179T patent/ATE423213T1/en not_active IP Right Cessation
- 1994-09-01 AU AU78334/94A patent/AU7833494A/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9506742A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US5362865A (en) | 1994-11-08 |
| US5659122A (en) | 1997-08-19 |
| CA2169854A1 (en) | 1995-03-09 |
| CA2169854C (en) | 2007-04-17 |
| AU7833494A (en) | 1995-03-22 |
| DE69435187D1 (en) | 2009-04-02 |
| WO1995006742A1 (en) | 1995-03-09 |
| ATE423213T1 (en) | 2009-03-15 |
| EP0716709B1 (en) | 2009-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0716709B1 (en) | Enhanced expression in plants using non-translated leader sequences | |
| AU767146B2 (en) | Plant expression vectors | |
| Carrington et al. | Cap-independent enhancement of translation by a plant potyvirus 5'nontranslated region | |
| Elmayan et al. | Evaluation in tobacco of the organ specificity and strength of the rolD promoter, domain A of the 35S promoter and the 35S2 promoter | |
| AU2007201884B2 (en) | Regulatory element from a sugarcane proline rich protein and uses thereof | |
| US20020192813A1 (en) | Plant expression vectors | |
| EP0459643A2 (en) | A recombinant promoter for gene expression in monocotyledonous plants | |
| WO2002042450A1 (en) | Sugarcane bacilliform virus promoters derived from isolates isolated from sugarcane cultivars | |
| US6833492B2 (en) | Nitrogen transport metabolism | |
| CA2565423A1 (en) | Enhanced expression in plants using non-translated leader sequences | |
| US20030024007A1 (en) | Plant Myb transcription factor homologs | |
| US10415047B2 (en) | TaBV transcriptional control elements, chimeric constructs and uses therefor | |
| Sanfaçon | Regulation of mRNA formation in plants: lessons from the cauliflower mosaic virus transcription signals | |
| US7053265B2 (en) | Application of bi-directional promoters for modification of gene expression | |
| JPH06228193A (en) | Trans-acting factor i | |
| US6294658B1 (en) | Factors involved in gene expression | |
| US20050102711A1 (en) | Banana actin gene and its promoter | |
| AU2008212072B2 (en) | Regulatory element from a sugarcane proline rich protein and uses thereof | |
| Nelsen | The role of wheat Em gene non-coding sequences in post-transcriptional regulation of gene expression | |
| AU2002216839A1 (en) | Banana actin gene and its promoter | |
| Liu | Analysis of ABA-regulated expression of the maize Glb1 gene in tobacco seeds and maize cells | |
| MXPA01001796A (en) | Plant expression vectors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19960227 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: LT PAYMENT 960227;SI PAYMENT 960227 |
|
| RAX | Requested extension states of the european patent have changed |
Free format text: LT PAYMENT 960227;SI PAYMENT 960227 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MONSANTO TECHNOLOGY LLC |
|
| 17Q | First examination report despatched |
Effective date: 20020626 |
|
| 17Q | First examination report despatched |
Effective date: 20020626 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Extension state: LT SI |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REF | Corresponds to: |
Ref document number: 69435187 Country of ref document: DE Date of ref document: 20090402 Kind code of ref document: P |
|
| LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20090218 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090218 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090529 |
|
| NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090518 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090218 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090720 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090218 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20091119 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090930 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20100531 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090901 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090930 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090930 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090519 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090930 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090901 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20130927 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20130927 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20130924 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20130927 Year of fee payment: 20 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69435187 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69435187 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20140831 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20140902 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20140831 |